Literature DB >> 16303161

Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.

Kotaro Shirakawa1, Akifumi Takaori-Kondo, Masayuki Kobayashi, Mitsunori Tomonaga, Taisuke Izumi, Keiko Fukunaga, Amane Sasada, Aierken Abudu, Yasuhiro Miyauchi, Hirofumi Akari, Kazuhiro Iwai, Takashi Uchiyama.   

Abstract

APOBEC3 proteins are antiviral host factors for a wide variety of retroviruses. HIV-1 Vif overcomes the antiviral activity of APOBEC3G by ubiquitinating the protein. In this study, we examined the ability of Vif to antagonize other family members of APOBEC3 proteins, together with its mechanism. Using HIV infectivity, virion incorporation, immunoprecipitation, and in vitro ubiquitin conjugation assays, we show that the ability of Vif to inhibit antiviral activity of APOBEC3 proteins positively correlates with its ability to bind and ubiquitinate these proteins by a Vif-Cullin5-ElonginB-ElonginC (Vif-BC-Cul5) complex. These results suggest that Vif exhibits its anti-APOBEC3 activity by the ubiquitin ligase activity of the Vif-BC-Cul5 complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303161     DOI: 10.1016/j.virol.2005.10.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

Review 1.  APOBEC family proteins: novel antiviral innate immunity.

Authors:  Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.

Authors:  Jared R Auclair; Karin M Green; Shivender Shandilya; James E Evans; Mohan Somasundaran; Celia A Schiffer
Journal:  Proteins       Date:  2007-11-01

3.  Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.

Authors:  Ke Zhao; Juan Du; Yajuan Rui; Wenwen Zheng; Jian Kang; Jingwei Hou; Kang Wang; Wenyan Zhang; Viviana A Simon; Xiao-Fang Yu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay.

Authors:  Lei Fang; Nathaniel R Landau
Journal:  Virology       Date:  2006-10-17       Impact factor: 3.616

5.  Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Katsuhiro Io; Kohei Tada; Fumie Iwai; Masayuki Kobayashi; Norimitsu Kadowaki; Reuben S Harris; Akifumi Takaori-Kondo
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

6.  Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.

Authors:  Xiaohong Zhou; Xue Han; Ke Zhao; Juan Du; Sean L Evans; Hong Wang; Peng Li; Wenwen Zheng; Yajuan Rui; Jian Kang; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 7.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

8.  Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

Authors:  Robert C Walker; Mohammad A Khan; Sandra Kao; Ritu Goila-Gaur; Eri Miyagi; Klaus Strebel
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

9.  Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Authors:  Lindi Tan; Phuong Thi Nguyen Sarkis; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

10.  Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.

Authors:  Atanu Maiti; Wazo Myint; Krista A Delviks-Frankenberry; Shurong Hou; Tapan Kanai; Vanivilasini Balachandran; Christina Sierra Rodriguez; Rashmi Tripathi; Nese Kurt Yilmaz; Vinay K Pathak; Celia A Schiffer; Hiroshi Matsuo
Journal:  J Mol Biol       Date:  2020-10-22       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.